CMS certification 260040
Cox Medical Centers
3801 South National Avenue, Springfield, MO 65807
Cox Medical Centers has a CMS overall rating of 3 out of 5 stars. 71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 3. Emergency patients spend a median of 3 h 39 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,234 completed surveys, 23% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MO | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 346 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 39 min | 2 h 35 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 15 visits sampled | 4 h 31 min | 4 h 23 min | 4 h 17 min |
| Left before being seen Lower is better · 104,072 patients | 3% | 3% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 15 patients | 47% | 74% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 165 patients | 66% | 63% | 65% |
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 6,663 cases | Too few cases | 3.5% | 3.9% |
| Heart attack 231 cases | Too few cases | 12.3% | 11.9% |
| Heart failure 439 cases | Too few cases | 13.4% | 11.1% |
| Pneumonia 641 cases | Too few cases | 12.3% | 15.2% |
| Stroke 874 cases | Too few cases | 14.1% | 11.9% |
| COPD 234 cases | Too few cases | 7.3% | 8.6% |
| Heart bypass surgery (CABG) 207 cases | Too few cases | 2.5% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.2 likely 0.96 – 1.44 | 1 |
| After hip or knee replacement 56 cases | Too few cases | 4.3% | 4.1% |
| Deaths after a serious but treatable surgical complication 159 cases | No different | 196.74 per 1,000 likely 158.57 per 1,000 – 234.92 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 9,354 cases | Worse | 1.26 per 1,000 likely 0.73 per 1,000 – 1.79 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 10,449 cases | No different | 0.22 per 1,000 likely 0.03 per 1,000 – 0.4 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 10,960 cases | No different | 0.3 per 1,000 likely 0.12 per 1,000 – 0.48 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,065 cases | No different | 2.54 per 1,000 likely 1.31 per 1,000 – 3.78 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,511 cases | No different | 2.58 per 1,000 likely 1.27 per 1,000 – 3.89 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,464 cases | No different | 10.41 per 1,000 likely 6.1 per 1,000 – 14.73 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,221 cases | No different | 3.47 per 1,000 likely 1.85 per 1,000 – 5.09 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,462 cases | No different | 3.85 per 1,000 likely 1.03 per 1,000 – 6.67 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 740 cases | No different | 2.29 per 1,000 likely 0.9 per 1,000 – 3.67 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,249 cases | No different | 0.93 per 1,000 likely 0.11 per 1,000 – 1.76 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.42 likely 0.2 – 0.77 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.53 likely 0.32 – 0.82 | 1 |
| Surgical site infections after colon surgery | No different | 0.6 likely 0.28 – 1.14 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.8 likely 0.13 – 2.65 | 1 |
| MRSA bloodstream infections | Better | 0.2 likely 0.05 – 0.56 | 1 |
| C. diff intestinal infections | Better | 0.47 likely 0.34 – 0.62 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 544 cases | Too few cases | 14.9% | 14.4% |
| Readmitted after heart failure 767 cases | Too few cases | 19.8% | 21.3% |
| Readmitted after pneumonia 1,301 cases | Too few cases | 16.8% | 17.3% |
| Readmitted after COPD 596 cases | Too few cases | 19.9% | 20% |
| Readmitted after heart bypass surgery 290 cases | Too few cases | 10.5% | 11% |
| Readmitted after hip or knee replacement 58 cases | Too few cases | 6.1% | 5.8% |
| Days back in hospital after a heart attack 271 cases | Too few cases | 49.1 days per 100 | — |
| Days back in hospital after heart failure 475 cases | Too few cases | 28.8 days per 100 | — |
| Days back in hospital after pneumonia 670 cases | Too few cases | -5.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 3,588 cases | No different | 12.6 per 1,000 likely 10.2 per 1,000 – 15.7 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 262 cases | No different | 11 per 100 likely 8.7 per 100 – 13.8 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 262 cases | No different | 5.1 per 100 likely 3.7 per 100 – 7.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,811 cases | No different | 1 likely 0.9 – 1.2 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
363 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Anesthesiology | 36 |
| Emergency Medicine | 34 |
| Anesthesiologist Assistant | 32 |
| Physician Assistant | 32 |
| Internal Medicine | 28 |
| Family | 21 |
| Diagnostic Radiology | 15 |
| Nurse Practitioner | 15 |
| Neonatal-Perinatal Medicine | 13 |
| Neurological Surgery | 10 |
| Family Medicine | 9 |
| Medical | 8 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $243,233
- 2020 $140,503
- 2021 $105,269
- 2022 $163,056
- 2023 $133,966
- 2024 $114,078
- 2025 $148,410
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Space rental and facility fees | $18,750 | 16 |
| Speaking, teaching and other services | $14,500 | 16 |
| Medical devices and supplies on long-term loan | $8,838 | 2 |
| Grants | $5,000 | 2 |
| Debt forgiveness | $3,872 | 15 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Research & Development, LLC | $57,343 | 15 |
| Abbvie INC. | $20,493 | 6 |
| W. L. Gore & Associates, Inc. | $13,100 | 3 |
| Insulet Corporation | $11,600 | 11 |
| Stryker Corporation | $9,035 | 4 |
| Genentech, Inc. | $4,900 | 2 |
| Baxter Healthcare | $3,674 | 13 |
| Merck Sharp & Dohme LLC | $3,615 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) Janssen Research & Development, LLC | $42,143 |
| A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects with FR-Expressing Advanced-Stage Serous Epithelial … ABBVIE INC. | $15,850 |
| A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) Janssen Research & Development, LLC | $15,200 |
| Evaluation of the GORE Ascending Stent Graft in the Treatment of Isolated Lesions, Pseudoaneurysms, and Penetrating Aortic Ulcers of Ascending Aorta … W. L. Gore & Associates, Inc. · NCT05800743 | $8,500 |
| Tiragolumab Tecentriq vs Durvalumab in Unresectable Stage III NSCLC Genentech, Inc. | $4,900 |
| GREAT Global Registry for Endovascular Aortic Treatment W. L. Gore & Associates, Inc. · NCT01658787 | $4,600 |
| A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants with EGFR-mutated, Advanced Non-squamous Non-small Cell Lung… Merck Sharp & Dohme LLC | $3,615 |
| M18-868 - A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participa… ABBVIE INC. | $2,643 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Cox Medical Centers
Is Cox Medical Centers a good hospital?
Cox Medical Centers has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Cox Medical Centers?
71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,234 completed HCAHPS surveys.
How long is the wait in the Cox Medical Centers emergency room?
Emergency patients spend a median of 3 h 39 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Cox Medical Centers receive money from drug and device companies?
Drug and device makers reported $148,410 in payments to Cox Medical Centers for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.